Ivabradine PCD Pharma Franchise Company
Cafoli Lifecare is a trusted Ivabradine PCD pharma franchise company offering 2 tablet formulations. Manufactured at WHO-GMP certified facilities, this range gives franchise partners a specialist cardiology molecule with strong guideline backing for angina and heart-failure management.
What is Ivabradine?
Ivabradine is a selective inhibitor of the funny current (If) in the sinoatrial node, the heart’s natural pacemaker. By slowing the pacemaker firing rate it reduces heart rate without affecting myocardial contractility, blood pressure or conduction. This pure heart-rate-lowering action reduces myocardial oxygen demand. Learn more on PubChem.
Therapeutic Applications of Ivabradine
Ivabradine is indicated for chronic stable angina pectoris in patients who cannot tolerate or are inadequately controlled on beta-blockers, and for chronic heart failure with reduced ejection fraction and an elevated resting heart rate. It is prescribed mainly by cardiologists and consulting physicians.
Why Ivabradine is a High-Potential Molecule for Distributors
Cardiovascular disease is the leading cause of death in India and heart-failure prevalence is climbing, expanding the pool of patients who benefit from heart-rate control. As a guideline-endorsed, patent-era-graduated molecule with a distinct niche where beta-blockers fall short, ivabradine offers distributors a premium, specialist-driven cardiology product with durable prescription loyalty.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers exclusive district-wise monopoly rights, WHO-GMP certified and DCGI-approved formulations, attractive promotional inputs and marketing support, and the reliability of a network trusted by 1000+ franchise partners across India.
References
- PubChem – Ivabradine Compound Summary, U.S. National Library of Medicine
- PubMed – Clinical literature on Ivabradine
Our formulations of Ivabradine find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: